Trials have flagged some concerns not typical of Wegovy: increased heart rate, irregular heartbeats in 2-11% of participants, and dysesthesia
Safety Considerations While semaglutide demonstrates clear cardiovascular benefits, treatment discontinuation rates merit attention
The MeAgain GLP-1 app helps by organizing symptom tracking in one place
patients with Type 2 diabetes from its previous list price of nearly $1,000 to just $499
Your providers goal is to determine not just if you qualify, but if semaglutide is a safe and appropriate fit for your specific situation
As the study authors put it, patients could be counseled to expect a partial return of baseline appetite sensations after the first months of treatment, but, despite these changes, they will continue to eat less food. Nearly all participants reported at least one adverse event